Profile
James A. Vollins is currently the Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. Prior to this, he held the same position at BioDelivery Sciences International, Inc. from 2018 to 2022 and at Bio Products Laboratory Ltd. from 2014 to 2018.
Vollins received his undergraduate degree from Wesleyan University and his graduate degree from Case Western Reserve University School of Law.
James Vollins active positions
| Companies | Position | Start |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Compliance Officer | 13/04/2023 |
Former positions of James Vollins
| Companies | Position | End |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 22/03/2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. BiotechnologyHealth Technology Manufactures and supplies human blood plasma products | Compliance Officer | 01/10/2018 |
Training of James Vollins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. BiotechnologyHealth Technology Manufactures and supplies human blood plasma products | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
- Stock Market
- Insiders
- James Vollins
















